CD274 and type 1 diabetes mellitus: Interestingly, the type I diabetes risk-associated MHC class 2 allele, HLA-DR4, is more prevalent in patients who develop diabetes as an irAE in anti- PD-1 and PD-L1 therapy than what is normally found in the US Caucasian population [57].